USPTO serial 79165147
DOMPE'
Reviewed by CopyMark Law Group
Reg. 4943605Status 739Renewal
- Filing date
- Status date
- Registration date
- Apr 26, 2016
- Examiner
- JONES, JACQUELYN ANDREA
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with DOMPE'?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*
Plus Government fees of $850
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Theodore R. Remaklus
Theodore R. Remaklus Thompson Hine LLP312 Walnut Street, Suite 2000Cincinnati, OH 45202-4024United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Pharmaceutical preparation for the treatment of respiratory diseases; pharmaceutical preparation for the treatment of bone diseases; analgesic and muscle relaxant pharmaceutical preparations; antibacterial pharmaceuticals; anti-epileptic pharmaceutical preparations; balms for pharmaceutical purposes; capsules sold empty for pharmaceuticals; cardiovascular pharmaceuticals; gelatin capsules sold empty for pharmaceuticals; ] ocular pharmaceuticals; pharmaceutical products for ophthalmological use [ ; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; pharmaceutical antitussive-cold pharmaceutical preparations for use in chemotherapy; pharmaceutical preparation for the treatment of rare diseases; pharmaceutical products for the treatment of viral and infectious diseases; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in anticoagulants; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the treatment of bacteria-based diseases and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations, namely, analgesic for human consumption taken orally; sanitary preparations for medical purposes; all-purpose disinfectants ] | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 15, 2026 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Jul 15, 2026 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Jul 13, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 30, 2026 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Apr 26, 2025 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Dec 26, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 26, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 26, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 26, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 26, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 25, 2024 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Jan 29, 2024 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jan 29, 2024 | INPC | INVALIDATION PROCESSED | — |
| Jan 18, 2024 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 18, 2023 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| May 18, 2023 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| May 16, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 26, 2022 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Jun 4, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Apr 26, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 12, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 4, 2019 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Aug 12, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 27, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 27, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 26, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 28, 2016 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 26, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 17, 2016 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Feb 9, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 9, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 5, 2016 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 20, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 20, 2016 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 20, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 29, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 10, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 7, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 7, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 11, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 22, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 22, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 19, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 18, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 17, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| May 22, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 18, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 15, 2015 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| May 14, 2015 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |